OTCMKTS:AXAHY - AXA Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 10
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$24.02
▼ -0.33 (-1.36%)
1 month | 3 months | 12 months
Get New AXA Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AXAHY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AXAHY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 10 analysts offering 12 month price targets for AXA in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $24.02.
Buy
The current consensus among 10 investment analysts is to buy stock in AXA. This rating has held steady since December 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 1 sell ratings
7/28/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
10/26/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 1 sell ratings
7/22/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 1 sell ratings
10/20/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 1 sell ratings
12/19/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 1 sell ratings
1/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetDetails
1/13/2021Morgan StanleyReiterated RatingOverweight
i
1/6/2021JPMorgan Chase & Co.Reiterated RatingOverweight
i
12/15/2020Societe GeneraleReiterated RatingBuy
i
12/15/2020Morgan StanleyReiterated RatingOverweight
i
11/24/2020BarclaysReiterated RatingOverweight
i
11/16/2020UBS GroupReiterated RatingNeutral
i
11/6/2020Morgan StanleyReiterated RatingOverweight
i
11/5/2020Nord/LBUpgradeHold ➝ Buy
i
10/16/2020Morgan StanleyReiterated RatingOverweight
i
9/17/2020Societe GeneraleReiterated RatingBuy
i
9/9/2020Berenberg BankUpgradeHold ➝ Buy
i
9/8/2020BarclaysReiterated RatingOverweight
i
8/10/2020Morgan StanleyReiterated RatingOverweight
i
7/22/2020Berenberg BankDowngradeBuy ➝ Hold
i
7/16/2020BarclaysReiterated RatingOverweight
i
7/15/2020CitigroupDowngradeNeutral ➝ Sell
i
Rating by James Shuck at Citigroup Inc.
7/1/2020Morgan StanleyReiterated RatingOverweight
i
6/30/2020JPMorgan Chase & Co.Reiterated RatingOverweight
i
6/30/2020UBS GroupReiterated RatingNeutral
i
6/30/2020CitigroupDowngradeBuy ➝ Neutral
i
5/11/2020Morgan StanleyReiterated RatingOverweight
i
4/29/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
4/21/2020Morgan StanleyReiterated RatingOverweight
i
3/11/2020Berenberg BankUpgradeHold ➝ Buy
i
3/6/2020Royal Bank of CanadaReiterated RatingOutperform
i
3/5/2020Berenberg BankInitiated CoverageHold ➝ Hold
i
12/4/2019BarclaysUpgradeEqual Weight ➝ Overweight
i
1/17/2019CitigroupUpgradeNeutral ➝ Buy
i
11/26/2018BarclaysReiterated RatingEqual Weight ➝ Equal Weight
i
10/8/2018Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform
i
9/24/2018JPMorgan Chase & Co.Initiated CoverageOverweight
i
9/3/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
i
3/20/2018CitigroupDowngradeBuy ➝ Neutral
i
3/6/2018MacquarieUpgradeUnderperform ➝ Neutral
i
1/12/2018CitigroupUpgradeNeutral ➝ Buy
i
1/25/2017BNP ParibasDowngradeOutperform ➝ Neutral
i
12/13/2016Credit Suisse GroupInitiated CoverageOutperform
i
5/4/2016JPMorgan Chase & Co.Reiterated RatingBuy
i
4/13/2016JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
i
3/22/2016JPMorgan Chase & Co.Reiterated RatingNeutral
i
3/16/2016CitigroupReiterated RatingBuy
i
2/25/2016DZ BankReiterated RatingBuy
i
2/16/2016JPMorgan Chase & Co.Reiterated RatingNeutral
i
(Data available from 1/19/2016 forward)
AXA logo
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health. Its products include motor, household, property and general liability insurance, banking, savings vehicles, and other investment-based products for personal/individual and commercial/group customers, as well as health, protection, and retirement products for individual or professional customers. The company also provides term life, whole life, universal life, endowment, and deferred and immediate annuities; medical cover; and other protection and health products, such as disability, cancer, and critical illness. In addition, it offers unit-linked, group term, and hospital cash products and investment products; and coverage against excess and surplus lines, environmental and professional liability, construction, marine, energy, aviation and satellite, fine art and specie, equine, livestock and aquaculture, accident and health and crisis management, and other risks. Further, the company provides casualty, property risk, property catastrophe, specialty, and other reinsurance lines; and individual and group retirement products, and employee benefits. Additionally, it is involved in the provision of investment management services through managed accounts, hedge funds, mutual funds, and other investment vehicles to private clients, as well as fundamental research, quantitative, and brokerage-related services in equities and listed options for institutional investors; management of retail mutual funds for individual investors; and management of investments on behalf of institutional clients. The company was founded in 1852 and is headquartered in Paris, France.
Read More

Today's Range

Now: $24.02
$23.81
$24.22

50 Day Range

MA: $24.11
$23.37
$25.05

52 Week Range

Now: $24.02
$12.72
$27.63

Volume

50,900 shs

Average Volume

60,487 shs

Market Capitalization

$58.01 billion

P/E Ratio

8.01

Dividend Yield

2.74%

Beta

1.45

Frequently Asked Questions

What sell-side analysts currently cover shares of AXA?

The following sell-side analysts have issued research reports on AXA in the last year: Barclays PLC, Berenberg Bank, Citigroup Inc., Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Nord/LB, Royal Bank of Canada, Societe Generale, UBS Group AG, and Zacks Investment Research.

What is the current price target for AXA?

0 Wall Street analysts have set twelve-month price targets for AXA in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for AXA in the next year.

What is the current consensus analyst rating for AXA?

AXA currently has 1 sell rating, 1 hold rating and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AXAHY will outperform the market and that investors should add to their positions of AXA.

What other companies compete with AXA?

How do I contact AXA's investor relations team?

AXA's physical mailing address is 25 avenue Matignon, Paris I0, 75008. The financial services provider's listed phone number is 33-1-40-75-57-00. The official website for AXA is www.axa.com.